Matches in Wikidata for { <http://www.wikidata.org/entity/Q65351853> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q65351853 description "clinical trial" @default.
- Q65351853 description "ensayu clínicu" @default.
- Q65351853 description "klinisch onderzoek" @default.
- Q65351853 description "клінічне випробування" @default.
- Q65351853 name "HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use Disorder" @default.
- Q65351853 name "HORIZANT" @default.
- Q65351853 type Item @default.
- Q65351853 label "HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use Disorder" @default.
- Q65351853 label "HORIZANT" @default.
- Q65351853 prefLabel "HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use Disorder" @default.
- Q65351853 prefLabel "HORIZANT" @default.
- Q65351853 P1132 Q65351853-61134005-077A-430B-A7C9-CB43520FB024 @default.
- Q65351853 P1476 Q65351853-229B1D6A-8217-477C-9AF5-32D5D549EBA0 @default.
- Q65351853 P17 Q65351853-62F59CAC-7A0D-4B26-96AB-83A03767DDDA @default.
- Q65351853 P2899 Q65351853-0A354218-EB71-4FB1-A6F3-BD7FD46A9766 @default.
- Q65351853 P3098 Q65351853-A44E5EAC-B93D-4FB6-8BBA-5EBBD63296AC @default.
- Q65351853 P31 Q65351853-016414B1-3407-4FC2-BF83-63456F7D33A8 @default.
- Q65351853 P580 Q65351853-9A3CDBAB-327E-48DA-AEAC-44810F2AE4FF @default.
- Q65351853 P582 Q65351853-9C84EA8A-EE5C-4E79-9B9D-7CA06EFA6996 @default.
- Q65351853 P6099 Q65351853-B4FECA3A-6E52-4B94-BB86-569DFAFB2B24 @default.
- Q65351853 P6153 Q65351853-5F314288-4323-4060-8903-1F71E637A7C0 @default.
- Q65351853 P6153 Q65351853-70B3F70F-2499-45C9-90A0-168A3CE5C31D @default.
- Q65351853 P6153 Q65351853-B087B548-1E82-44F8-BC34-1AB4DC73C57A @default.
- Q65351853 P8363 Q65351853-9D6123CE-A6BE-407E-88E6-B28B46B70E1B @default.
- Q65351853 P859 Q65351853-FE3BAA67-1400-4D8A-9FBD-4AC255850C19 @default.
- Q65351853 P1132 "+346" @default.
- Q65351853 P1476 "Randomized, Double Blind, Placebo-Controlled Trial of the Safety and Efficacy of HORIZANT (Gabapentin Enacarbil) Extended-Release Tablets for the Treatment of Alcohol Use Disorder" @default.
- Q65351853 P17 Q30 @default.
- Q65351853 P2899 "+21" @default.
- Q65351853 P3098 "NCT02252536" @default.
- Q65351853 P31 Q30612 @default.
- Q65351853 P580 "2015-06-01T00:00:00Z" @default.
- Q65351853 P582 "2017-03-01T00:00:00Z" @default.
- Q65351853 P6099 Q42824440 @default.
- Q65351853 P6153 Q213439 @default.
- Q65351853 P6153 Q49117 @default.
- Q65351853 P6153 Q5225736 @default.
- Q65351853 P8363 Q78089383 @default.
- Q65351853 P859 Q29011777 @default.